Autologous Multipotent Mesenchymal Stromal Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous Multipotent Mesenchymal Stromal Cells, covering 2019-02-12 to 2019-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]